Among the many news reports covering our recent trial victory for clients Claudio De Simone and ExeGi Pharma, LLC, the National Law Review ran a story on December 21, 2018 taking an in-depth look at the case, which is shaping up to be one of the leading verdicts in BioTech litigation in 2018. We are proud to stand with Professor Claudio De Simone and ExeGi Pharma in this fight and will continue to work zealously to protect their product, which has benefitted thousands of patients over more than 15 years. Click here to see the National Law Review article.
National Law Review Reports on Schulman Bhattacharya’s $18 Million Jury Trial Win
Comments are closed.